Mironid
Pre-clinicalMironid® is developing novel small-molecule therapeutics that directly target the central signalling mechanism that drives ADPKD.
Founded
2015
Focus
Small Molecules
About
Mironid® is developing novel small-molecule therapeutics that directly target the central signalling mechanism that drives ADPKD.
Company Info
TypePrivate
Founded2015
LocationEdinburgh, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile